Je selectiemandje is leeg.
Maak een selectie van ETF's die je wilt vergelijken.
Voeg een ETF toe door op "Vergelijk" te klikken op een ETF-profiel of door een ETF aan te vinken in de ETF-zoekfunctie.
Ipsen SA
ISIN FR0010259150
|WKN A0ESMG
Marktkapitalisatie (in EUR)
13,863 m
Land
France
Sector
Healthcare
Dividendrendement
0.85%
Overzicht
Koers
Beschrijving
Ipsen SA manufactures pharmaceutical products for oncology, neuroscience, and rare diseases. It operates through the following segments: Specialty Care. The Specialty Care segment focuses on oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and rare diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals France
Grafiek
Financiële kerngegevens
Kerncijfers
| Marktkapitalisatie, EUR | 13,863 m |
| WPA, EUR | - |
| KBV | 3.2 |
| K/W | 30.8 |
| Dividendrendement | 0.85% |
Winst- en verliesrekening (2025)
| Omzet, EUR | 3,676 m |
| Netto-inkomen, EUR | 444 m |
| Winstmarge | 12.07% |
In welke ETF zit Ipsen SA?
Er zijn 57 ETF's die Ipsen SA bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van Ipsen SA is de Amundi S&P Eurozone Dividend Aristocrat Screened UCITS ETF Dist.
Prestaties
Rendementsoverzicht
| YTD | +35,74% |
| 1 maand | +3,83% |
| 3 maanden | +18,49% |
| 6 maanden | +33,35% |
| 1 jaar | +62,70% |
| 3 jaar | +47,82% |
| 5 jaar | +102,02% |
| Since inception | +111,42% |
| 2025 | +8,65% |
| 2024 | +2,08% |
| 2023 | +6,92% |
| 2022 | +24,94% |
Maandelijks rendement in een heat map
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Volatiliteit 1 jaar | 25,13% |
| Volatiliteit 3 jaar | 24,71% |
| Volatiliteit 5 jaar | 27,31% |
| Rendement/Risico 1 jaar | 2,49 |
| Rendement/Risico 3 jaar | 0,56 |
| Rendement/Risico 5 jaar | 0,55 |
| Maximaal waardedaling 1 jaar | -11,78% |
| Maximaal waardedaling 3 jaar | -29,88% |
| Maximaal waardedaling 5 jaar | -31,93% |
| Maximaal waardedaling sinds aanvang | -31,93% |
Voortschrijdende volatiliteit over 1 jaar
Nieuwste artikelen
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.